The global market for Omega 3 Prescription Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Omega 3 Prescription Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Omega 3 Prescription Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Omega 3 Prescription Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Omega 3 Prescription Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Omega 3 Prescription Drug players cover Abbott, Amarin Pharmaceuticals Ireland Ltd., GSK plc (GlaxoSmithKline plc), Natrapharm, Inc. (Patriot Pharmaceutical Corp.) and Viatris, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Omega 3 Prescription Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Omega 3 Prescription Drug market, with both quantitative and qualitative data, to help readers understand how the Omega 3 Prescription Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Omega 3 Prescription Drug market and forecasts the market size by Type (Vascepa, Lovaza and Others), by Application (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Vascepa
Lovaza
Others
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott
Amarin Pharmaceuticals Ireland Ltd.
GSK plc (GlaxoSmithKline plc)
Natrapharm, Inc. (Patriot Pharmaceutical Corp.)
Viatris, Inc.
Grupo Ferrer Internacional, S.A.
Camber Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Ltd.
Zydus Group
Hikma Pharmaceuticals PLC
Chapter Introduction
Chapter 1: Scope of Omega 3 Prescription Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Omega 3 Prescription Drug market size and CAGR, Omega 3 Prescription Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Omega 3 Prescription Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Omega 3 Prescription Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Omega 3 Prescription Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott, Amarin Pharmaceuticals Ireland Ltd., GSK plc (GlaxoSmithKline plc), Natrapharm, Inc. (Patriot Pharmaceutical Corp.), Viatris, Inc., Grupo Ferrer Internacional, S.A., Camber Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd. and Zydus Group and etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Omega 3 Prescription Drug Market Size 2017-2028
2.1.2 Omega 3 Prescription Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Omega 3 Prescription Drug Segment by Type
2.2.1 Vascepa
2.2.2 Lovaza
2.2.3 Others
2.3 Omega 3 Prescription Drug Market Size by Type
2.3.1 Omega 3 Prescription Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Omega 3 Prescription Drug Market Size Market Share by Type (2017-2022)
2.4 Omega 3 Prescription Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Omega 3 Prescription Drug Market Size by Application
2.5.1 Omega 3 Prescription Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Omega 3 Prescription Drug Market Size Market Share by Application (2017-2022)
3 Omega 3 Prescription Drug Market Size by Player
3.1 Omega 3 Prescription Drug Market Size Market Share by Players
3.1.1 Global Omega 3 Prescription Drug Revenue by Players (2020-2022)
3.1.2 Global Omega 3 Prescription Drug Revenue Market Share by Players (2020-2022)
3.2 Global Omega 3 Prescription Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Omega 3 Prescription Drug by Regions
4.1 Omega 3 Prescription Drug Market Size by Regions (2017-2022)
4.2 Americas Omega 3 Prescription Drug Market Size Growth (2017-2022)
4.3 APAC Omega 3 Prescription Drug Market Size Growth (2017-2022)
4.4 Europe Omega 3 Prescription Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Omega 3 Prescription Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Omega 3 Prescription Drug Market Size by Country (2017-2022)
5.2 Americas Omega 3 Prescription Drug Market Size by Type (2017-2022)
5.3 Americas Omega 3 Prescription Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Omega 3 Prescription Drug Market Size by Region (2017-2022)
6.2 APAC Omega 3 Prescription Drug Market Size by Type (2017-2022)
6.3 APAC Omega 3 Prescription Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Omega 3 Prescription Drug by Country (2017-2022)
7.2 Europe Omega 3 Prescription Drug Market Size by Type (2017-2022)
7.3 Europe Omega 3 Prescription Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Omega 3 Prescription Drug by Region (2017-2022)
8.2 Middle East & Africa Omega 3 Prescription Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Omega 3 Prescription Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Omega 3 Prescription Drug Market Forecast
10.1 Global Omega 3 Prescription Drug Forecast by Regions (2023-2028)
10.1.1 Global Omega 3 Prescription Drug Forecast by Regions (2023-2028)
10.1.2 Americas Omega 3 Prescription Drug Forecast
10.1.3 APAC Omega 3 Prescription Drug Forecast
10.1.4 Europe Omega 3 Prescription Drug Forecast
10.1.5 Middle East & Africa Omega 3 Prescription Drug Forecast
10.2 Americas Omega 3 Prescription Drug Forecast by Country (2023-2028)
10.2.1 United States Omega 3 Prescription Drug Market Forecast
10.2.2 Canada Omega 3 Prescription Drug Market Forecast
10.2.3 Mexico Omega 3 Prescription Drug Market Forecast
10.2.4 Brazil Omega 3 Prescription Drug Market Forecast
10.3 APAC Omega 3 Prescription Drug Forecast by Region (2023-2028)
10.3.1 China Omega 3 Prescription Drug Market Forecast
10.3.2 Japan Omega 3 Prescription Drug Market Forecast
10.3.3 Korea Omega 3 Prescription Drug Market Forecast
10.3.4 Southeast Asia Omega 3 Prescription Drug Market Forecast
10.3.5 India Omega 3 Prescription Drug Market Forecast
10.3.6 Australia Omega 3 Prescription Drug Market Forecast
10.4 Europe Omega 3 Prescription Drug Forecast by Country (2023-2028)
10.4.1 Germany Omega 3 Prescription Drug Market Forecast
10.4.2 France Omega 3 Prescription Drug Market Forecast
10.4.3 UK Omega 3 Prescription Drug Market Forecast
10.4.4 Italy Omega 3 Prescription Drug Market Forecast
10.4.5 Russia Omega 3 Prescription Drug Market Forecast
10.5 Middle East & Africa Omega 3 Prescription Drug Forecast by Region (2023-2028)
10.5.1 Egypt Omega 3 Prescription Drug Market Forecast
10.5.2 South Africa Omega 3 Prescription Drug Market Forecast
10.5.3 Israel Omega 3 Prescription Drug Market Forecast
10.5.4 Turkey Omega 3 Prescription Drug Market Forecast
10.5.5 GCC Countries Omega 3 Prescription Drug Market Forecast
10.6 Global Omega 3 Prescription Drug Forecast by Type (2023-2028)
10.7 Global Omega 3 Prescription Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Omega 3 Prescription Drug Product Offered
11.1.3 Abbott Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Amarin Pharmaceuticals Ireland Ltd.
11.2.1 Amarin Pharmaceuticals Ireland Ltd. Company Information
11.2.2 Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Product Offered
11.2.3 Amarin Pharmaceuticals Ireland Ltd. Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Amarin Pharmaceuticals Ireland Ltd. Main Business Overview
11.2.5 Amarin Pharmaceuticals Ireland Ltd. Latest Developments
11.3 GSK plc (GlaxoSmithKline plc)
11.3.1 GSK plc (GlaxoSmithKline plc) Company Information
11.3.2 GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Product Offered
11.3.3 GSK plc (GlaxoSmithKline plc) Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GSK plc (GlaxoSmithKline plc) Main Business Overview
11.3.5 GSK plc (GlaxoSmithKline plc) Latest Developments
11.4 Natrapharm, Inc. (Patriot Pharmaceutical Corp.)
11.4.1 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Company Information
11.4.2 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Product Offered
11.4.3 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Main Business Overview
11.4.5 Natrapharm, Inc. (Patriot Pharmaceutical Corp.) Latest Developments
11.5 Viatris, Inc.
11.5.1 Viatris, Inc. Company Information
11.5.2 Viatris, Inc. Omega 3 Prescription Drug Product Offered
11.5.3 Viatris, Inc. Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Viatris, Inc. Main Business Overview
11.5.5 Viatris, Inc. Latest Developments
11.6 Grupo Ferrer Internacional, S.A.
11.6.1 Grupo Ferrer Internacional, S.A. Company Information
11.6.2 Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Product Offered
11.6.3 Grupo Ferrer Internacional, S.A. Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Grupo Ferrer Internacional, S.A. Main Business Overview
11.6.5 Grupo Ferrer Internacional, S.A. Latest Developments
11.7 Camber Pharmaceuticals, Inc.
11.7.1 Camber Pharmaceuticals, Inc. Company Information
11.7.2 Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Product Offered
11.7.3 Camber Pharmaceuticals, Inc. Omega 3 Prescription Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Camber Pharmaceuticals, Inc. Main Business Overview
11.7.5 Camber Pharmaceuticals, Inc. Latest Developments
11.8 Dr. Reddy
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)